Trademark: VERNX 1921251
Word
VERNX
ID
1921251
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
20 April 2018
Registration Date
20 April 2018
Renewal Date
20 April 2028
Owner(s)
Service
Minter Ellison
Goods and Services:
Class 5:
Pharmaceutical preparations; medicines for human use; pharmaceutical products; chemical preparations for pharmaceutical purposes; chemicals for pharmaceutical use; diagnostic preparations for medical purposes; pharmaceutical, herbal supplements and veterinary preparations for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system
Pharmaceutical preparations; medicines for human use; pharmaceutical products; chemical preparations for pharmaceutical purposes; chemicals for pharmaceutical use; diagnostic preparations for medical purposes; pharmaceutical, herbal supplements and veterinary preparations for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system
Class 42:
Scientific and technological services and research and design relating thereto; research services; scientific research services; scientific research into the development of new products; preparation of reports relating to scientific research; analytical laboratory services; laboratory research and analysis; development of products; development of new products; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services; all of the aforesaid services in relation to the improvement of the gastrointestinal system in premature infants and branched fat active ingredients; all of the aforesaid services not in relation to pharmaceutical preparations
Scientific and technological services and research and design relating thereto; research services; scientific research services; scientific research into the development of new products; preparation of reports relating to scientific research; analytical laboratory services; laboratory research and analysis; development of products; development of new products; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services; all of the aforesaid services in relation to the improvement of the gastrointestinal system in premature infants and branched fat active ingredients; all of the aforesaid services not in relation to pharmaceutical preparations